Država: Nemčija
Jezik: angleščina
Source: HMA (Heads of Medicines Agencies)
marbofloxacin 0 %
Norbrook Laboratories Limited
QJ01MA93
Injection
marbofloxacin
Cattle
2012-09-26
Dokument1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Marbonor SOLO 100 mg/ml Solution for Injection for Cattle. (AT, BG, CY, FR, DE, EL, IE, PL, PT, RO, UK Marbonor 100 mg/ml dosis única solución inyectable para bovino (ES) Boroflox Cattle 100 mg/ml Solution for Injection (IT) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Marbofloxacin 100.0 mg EXCIPIENTS: Monothioglycerol 1.0 mg Metacresol 2.0 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear yellow to amber solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of respiratory infections caused by susceptible strains of _Pasteurella multocida, Mannheimia haemolytica_ and _Histophilus somni_. 4.3 CONTRAINDICATIONS Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross-resistance). Do not use in animals with known hypersensitivity to fluoroquinolones or to any of the excipients. Dokument1 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE (I)SPECIAL PRECAUTIONS FOR USE IN ANIMALS Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other Preberite celoten dokument